A
$ Value
$37K
Shares
155
Price
$242
Filed
Mar 12
Insider
Name
Woods Eugene A.
Title
—
CIK
0001762647
Roles
Director
Transaction Details
Transaction Date
2026-03-10
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
5,240
Footnotes
Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. | Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Filing Info
Woods Eugene A.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | JNJ | A | $37K |
| 2025-12-09 | JNJ | A | $37K |
| 2025-09-09 | JNJ | A | $37K |
| 2025-06-10 | JNJ | A | $36K |
| 2025-04-24 | JNJ | A | $0 |
Other Insiders at JNJ (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
REED JOHN C
EVP, Innovative Medicine, R&D
|
— | $13.1M | 2026-02-17 |
| HEWSON MARILLYN A | — | — | 2026-03-10 |
| Pinto Daniel E | — | — | 2026-03-10 |
|
Duato Joaquin
CEO and Chairman of the Board
|
— | $22.1M | 2026-02-15 |
|
Wolk Joseph J
Exec VP, CFO
|
— | $21.8M | 2026-02-17 |
|
Taubert Jennifer L
EVP, WWC. Innovative Medicine
|
— | — | 2026-02-15 |
|
Wengel Kathryn E
EVP, Chief TO and Risk Officer
|
— | — | 2026-02-15 |
|
Decker Robert J
VP Corporate Controller
|
— | $1.0M | 2026-02-27 |
|
Swanson James D.
EVP, CIO
|
— | $15.1M | 2026-02-17 |
|
Broadhurst Vanessa
EVP, Global Corp Affairs
|
— | $1.5M | 2026-02-17 |
|
Forminard Elizabeth
EVP, Chief Legal Officer
|
— | — | 2026-02-15 |
|
Schmid Timothy
EVP, WW Chair, MedTech
|
— | $5.9M | 2026-02-20 |
|
Mulholland Kristen
EVP, Chief HR Officer
|
— | — | 2026-02-15 |